Maintaining the quality of vaccines through the use of standards: Current challenges and future opportunities

Biologicals. 2024 Mar 12;86:101756. doi: 10.1016/j.biologicals.2024.101756. Online ahead of print.ABSTRACTAn international hybrid meeting held 21-22 June 2023 in Ottawa, Canada brought together regulators, scientists, and industry experts to discuss a set of principles and best practices in the development and implementation of standards. Although the use of international standards (ISs) and international units (IUs) has been an essential part of ensuring human and animal vaccine quality in the past decades, the types and uses of standards have expanded with technological advances in manufacture and testing of vaccines. The needs of stakeholders are evolving in response to the ever-increasing complexity, diversity, and number of vaccine products as well as increasing efforts to replace animal-based potency tests with in vitro assays that measure relevant quality attributes. As such, there must be a concomitant evolution in the design and implementation of both international and in-house standards. Concomitantly, greater harmonization of regulatory expectations must be achieved through collaboration with standard-setting organizations, national control laboratories and manufacturers. Stakeholders provided perspectives on challenges and several recommendations emerged as essential to advancing agreed upon objectives.PMID:38479213 | DOI:10.1016/j.biologicals.2024.101756
Source: Biologicals : Journal of the International Association of Biological Standardization - Category: Biotechnology Authors: Source Type: research